In Brief: Upcoming NDAC meetings
This article was originally published in The Tan Sheet
Executive Summary
Upcoming NDAC meetings: FDA's Nonprescription Drugs Advisory Committee is tentatively set to meet with the Endocrinologic & Metabolic Drugs Advisory Committee on Sept. 27; with the Drug Abuse Advisory Committee on Sept. 28; and with the Gastrointestinal Drugs Advisory Committee on Sept. 29. The session with the Drug Abuse committee is expected to address smoking cessation aids, an area in which SmithKline Beecham's Nicorette nicotine gum Rx-to-OTC switch application is pending...